Skip to main content
Top
Published in: Journal of Endocrinological Investigation 2/2021

01-02-2021 | Osteoporosis | Original Article

Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women

Authors: S. Liu, R. Chen, N. Ding, Q. Wang, M. Huang, H. Liu, Z. Xie, Y. Ou, Z. Sheng

Published in: Journal of Endocrinological Investigation | Issue 2/2021

Login to get access

Abstract

Purpose

Despite the large number of osteoporosis patients in China, the diagnosis and treatment rates remain low. The Fracture Risk Assessment Tool (FRAX) can be used to effectively evaluate fracture risk. In this study, we explored the Chinese-specific thresholds of FRAX without the T-score.

Methods

In all, 264 postmenopausal women aged > 50 years were randomly recruited from community-medical centers. All subjects completed self-reported questionnaires, BMD measurements, and spinal radiographs. The 10-year hip and major osteoporotic fracture risks were calculated by FRAX. A new threshold for both 10-year hip and major osteoporotic fracture risk was explored with receiver operating characteristic (ROC) curve analysis.

Results

Overall, 92 subjects were diagnosed with osteoporosis. Among them, 14 participants with T-score > − 2.5 were diagnosed with osteoporosis based on clinical fractures. ROC analysis showed the cut-off value of the 10-year hip osteoporotic fracture for detecting osteoporosis was 0.95%, while that of 10-year major osteoporotic fracture was 4.95%. The sensitivity and specificity of the 10-year hip osteoporotic fracture probability for detecting osteoporosis were 0.86 and 0.59, respectively, while the guideline-recommended threshold had a sensitivity of 0.49 and specificity of 0.83. The sensitivity and specificity of the 10-year major osteoporotic fractures with the new threshold were 0.76 and 0.69, respectively, while the recommended threshold had a sensitivity of 0 and specificity of 1.

Conclusion

Current guideline-recommended FRAX thresholds without BMD showed low sensitivity. Therefore, 10-year osteoporotic hip fracture probability ≥ 0.95% and 10-year osteoporotic major fracture probability ≥ 4.95% are recommended as the new thresholds.
Literature
1.
go back to reference NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef
2.
go back to reference Black DM, Rosen CJ (2016) Clinical practice. Postmenopausal Osteoporosis N Engl J Med 374:254–262CrossRef Black DM, Rosen CJ (2016) Clinical practice. Postmenopausal Osteoporosis N Engl J Med 374:254–262CrossRef
3.
go back to reference Si L, Winzenberg TM, Jiang Q et al (2015) Projection of osteoporosis-related fractures and costs in China: 2010–2050. Osteoporos Int 26:1929–1937CrossRef Si L, Winzenberg TM, Jiang Q et al (2015) Projection of osteoporosis-related fractures and costs in China: 2010–2050. Osteoporos Int 26:1929–1937CrossRef
4.
go back to reference Melton LJ III, Chrischilles EA, Cooper C et al (2005) How many women have osteoporosis? JBMR anniversary classic. JBMR, volume 7, number 9, 1992. J Bone Miner Res 20:886–892CrossRef Melton LJ III, Chrischilles EA, Cooper C et al (2005) How many women have osteoporosis? JBMR anniversary classic. JBMR, volume 7, number 9, 1992. J Bone Miner Res 20:886–892CrossRef
5.
go back to reference US Preventive Services Task Force, Curry SJ, Krist AH et al (2018) Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA 319:2521–2531CrossRef US Preventive Services Task Force, Curry SJ, Krist AH et al (2018) Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA 319:2521–2531CrossRef
7.
go back to reference Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381CrossRef Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381CrossRef
9.
go back to reference Compston J, Cooper A, Cooper C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43CrossRef Compston J, Cooper A, Cooper C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43CrossRef
10.
go back to reference Liu SY, Huang M, Chen R et al (2019) Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model. Endocrine 65:200–206CrossRef Liu SY, Huang M, Chen R et al (2019) Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model. Endocrine 65:200–206CrossRef
11.
go back to reference Wang O, Hu Y, Gong S et al (2015) A survey of outcomes and management of patients post fragility fractures in China. Osteoporos Int 26:2631–2640CrossRef Wang O, Hu Y, Gong S et al (2015) A survey of outcomes and management of patients post fragility fractures in China. Osteoporos Int 26:2631–2640CrossRef
12.
go back to reference Sheng Z, Xu K, Ou Y et al (2011) Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf) 74:319–324CrossRef Sheng Z, Xu K, Ou Y et al (2011) Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf) 74:319–324CrossRef
13.
go back to reference Genant HK, Wu CY, van Kuijk C et al (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRef Genant HK, Wu CY, van Kuijk C et al (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRef
14.
go back to reference Grados F, Roux C, de Vernejoul MC et al (2001) Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int 12:716–722CrossRef Grados F, Roux C, de Vernejoul MC et al (2001) Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int 12:716–722CrossRef
15.
go back to reference Xia WB, He SL, Xu L et al (2012) Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res 27:125–129CrossRef Xia WB, He SL, Xu L et al (2012) Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res 27:125–129CrossRef
16.
go back to reference Tian FM, Zhang L, Zhao HY et al (2014) An increase in the incidence of hip fractures in Tangshan, China. Osteoporos Int 25:1321–1325CrossRef Tian FM, Zhang L, Zhao HY et al (2014) An increase in the incidence of hip fractures in Tangshan, China. Osteoporos Int 25:1321–1325CrossRef
17.
go back to reference WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129 WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
18.
go back to reference Kim JW, Koh JM, Park JH et al (2015) Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010). Bone 75:27–31CrossRef Kim JW, Koh JM, Park JH et al (2015) Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010). Bone 75:27–31CrossRef
19.
go back to reference Oka R, Ohira M, Suzuki S et al (2018) Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey. Endocr J 65:193–202CrossRef Oka R, Ohira M, Suzuki S et al (2018) Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey. Endocr J 65:193–202CrossRef
20.
go back to reference Chen XF, Li XL, Zhang H et al (2014) Were you identified to be at high fracture risk by FRAX(R) before your osteoporotic fracture occurred? Clin Rheumatol 33:693–698CrossRef Chen XF, Li XL, Zhang H et al (2014) Were you identified to be at high fracture risk by FRAX(R) before your osteoporotic fracture occurred? Clin Rheumatol 33:693–698CrossRef
21.
go back to reference Xu J, Sun M, Wang Z et al (2013) Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population. Clin Interv Aging 8:789–796PubMedPubMedCentral Xu J, Sun M, Wang Z et al (2013) Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population. Clin Interv Aging 8:789–796PubMedPubMedCentral
Metadata
Title
Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women
Authors
S. Liu
R. Chen
N. Ding
Q. Wang
M. Huang
H. Liu
Z. Xie
Y. Ou
Z. Sheng
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 2/2021
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-020-01315-4

Other articles of this Issue 2/2021

Journal of Endocrinological Investigation 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine